Search
forResearch 10 of 1000+
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- Cutaneous alternariosis in a patient with idiopathic pulmonary fibrosis
- Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization
- Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
- NOVEL NANOPARTICULATE SYSTEMS FOR IDIOPATHIC PULMONARY FIBROSIS: A REVIEW
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Expression of transforming growth factor-β_1 and tumor necrosis factor-α in mice with radiationinduced pulmonary injury
- Resident macrophages of the lung and liver: The guardians of our tissues
Community 1
Learn
— no results
Try a deeper search in learn →